Xiamen Weijia Pharma Co., Ltd, founded in May 2017, is a "double hundred" enterprise in Xiamen. The company is located in the biomedical port of Haicang District, Xiamen city. It is committed to the development and industrialization of generic drugs, with the R & D and production of antiviral and anti AIDS drugs as the main direction. The treatment field covers AIDS, hepatitis B, cancer, rare diseases and other diseases. The company strives to provide customers with the most ideal products and the best service. Weijia Pharmaceutical (Shaowu) Co., Ltd., a wholly-owned subsidiary of Weijia pharmaceutical, was established in September 2018, mainly engaged in the research and development and production of intermediates, APIs, and preparations such as anti AIDS, rare diseases, and heavy popular generic drugs.